From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA urges drug companies to explore more unproven approaches in the cancer drug market

from Becker's Hospital Review

A new type of cancer drug that stimulates the immune system to fight off tumors allowed for huge breakthroughs for drug companies, but one top U.S. regulator believes too many companies are focused on the same approach. The therapies are designed to disable the PD-1 protein that tumors use to evade the immune system. Around 20 percent of advanced cancer patients respond to the new drugs, with some even having lasting remission. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063